[1] Bikbov B,Purcell C.A,Levey A.S,et al.GBD chronic kidney disease collaboration global,regional,and national burden of chronic kidney disease,1990-2017:a systematic analysis for the global burden of disease study 2017[J].Lancet,2020,395(10225):709-733. [2] Schunk S.J,Floege J,Fliser D,et al.WNT-β-catenin signalling-A versatile player in kidney injury and repair[J].Nat Rev Nephrol,2021,17(3):172-184. [3] Sanchez-Alamo B,Garcia-Inigo F.J,Shabaka A,et al.Urinary dickkopf-3:a new biomarker for CKD progression and mortality[J].Nephrol Dial Transplant,2021,36(12):2199-2207. [4] Seibert F.S,Heringhaus A,Pagonas N,et al.Dickkopf-3 in the prediction of contrast media induced acute kidney injury[J].Nephrol,2021,34(3):821-828. [5] Roscigno G,Quintavalle C,Biondi-Zoccai G,et al.Urinary dickkopf-3 and contrast-associated kidney damage[J].Am Coll Cardiol,2021,77(21):2667-2676. [6] Puthumana J,Thiessen-Philbrook H,Xu L,et al.Biomarkers of inflammation and repair in kidney disease progression[J].Clin Investig,2021,131(3):139927. [7] Wu L,Li X-Q,Chang D-Y,et al.Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease[J].Nephrol Dial Transplant,2020,35(2):291-297. [8] Menez S,Ju W,Menon R,et al.Urinary EGF and MCP-1 and risk of CKD after cardiac surgery[J].CI Insight,2021,6(11):147464. [9] Davies J.C,Carlsson E,Midgley A,et al.A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment[J].Rheumatology (Oxford),2021,60(8):3747-3759. [10] Gonzalez G.A.M,Lieske J,Klee G,et al.Urinary CD80 discriminates among glomerular disease types and reflects disease activity[J].Kidney Int Rep,2020,5(11):2021-2031. [11] Duan S,Chen J,Wu L,et al.Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease[J].Diabetes Complicat,2020,34(10):107665. [12] Gohda T,Kamei N,Koshida T,et al.Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease[J].Diabetes Investig,2020,11(2):435-440. [13] Cortvrindt C,Speeckaert R,Delanghe J.R,et al.Urinary epidermal growth factor:a promising “next generation” biomarker in kidney disease[J].Am Nephrol,2022,53(5):372-387. [14] Norvik J.V,Harskamp L.R,Nair V,et al.Urinary excretion of epidermal growth factor and rapid loss of kidney function[J].Nephrol Dial Transplant,2021,36(10):1882-1892. [15] Melchinger H,Calderon-Gutierrez F,Obeid W,et al.Urine uromodulin as a biomarker of kidney tubulointerstitial fibrosis[J].Clin Am Soc Nephrol,2022,17(9):1284-1292. [16] Verbeke F,Siwy J,Van Biesen W,et al.The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease[J].Nephrol Dial Transplant,2021,36(5):811-818. [17] Tofte N,Lindhardt M,Adamova K,et al.Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression(PRIORITY):a prospective observational study and embedded randomised placebo-controlled trial[J].Lancet Diabetes Endocrinol,2020,8(4):301-312. [18] Perez-Gomez M.V,Pizarro-Sanchez S,Gracia-Iguacel C,et al.Urinary growth differentiation factor-15 (GDF15) levels as a biomarker of adverse outcomes and biopsy findings in chronic kidney disease[J].Nephrol,2021,34(6):1819-1832. [19] Lee Y.H,Kim K.P,Park S-H,et al.Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease[J].Nephrol Dial Transplant,2021,36(2):295-305. [20] Ou S-M,Tsai M-T,Chen H-Y,et al.Urinary galectin-3 as a novel biomarker for the prediction of renal fibrosis and kidney disease progression[J].Biomedicines,2022,10(3):585. [21] Brondani L.d.A,Soares A.A,Recamonde-Mendoza M,et al.Urinary peptidomics and bioinformatics for the detection of diabetic kidney disease[J].Sci Rep,2020,10(1):1242. [22] Ahn H-S,Kim J.H,Jeong H,et al.Differential urinary proteome analysis for predicting prognosis in type 2 diabetes patients with and without renal dysfunction[J].Int Mol Sci,2020,21(12):4236. [23] Panizo S,Martínez-Arias L,Alonso-Montes C,et al.Fibrosis in chronic kidney disease:pathogenesis and consequences[J].Int Mol Sci,2021,22(1):408. [24] Catanese L,Siwy J,Mavrogeorgis E,et al.A novel urinary proteomics classifier for non-invasive evaluation of interstitial fibrosis and tubular atrophy in chronic kidney disease[J].Proteomes,2021,9(3):32. [25] Mavrogeorgis E,Mischak H,Latosinska A,et al.Collagen-derived peptides in CKD:a link to fibrosis[J].Toxins,2021,14(1):10.
2024, Vol. 30 
冀公网安备13080202000677号